BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29361246)

  • 1. Precision Matters in MR Imaging-targeted Prostate Biopsies: Evidence from a Prospective Study of Cognitive and Elastic Fusion Registration Transrectal Biopsies.
    Cornud F; Roumiguié M; Barry de Longchamps N; Ploussard G; Bruguière E; Portalez D; Malavaud B
    Radiology; 2018 May; 287(2):534-542. PubMed ID: 29361246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.
    Puech P; Rouvière O; Renard-Penna R; Villers A; Devos P; Colombel M; Bitker MO; Leroy X; Mège-Lechevallier F; Comperat E; Ouzzane A; Lemaitre L
    Radiology; 2013 Aug; 268(2):461-9. PubMed ID: 23579051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation.
    Galosi AB; Maselli G; Sbrollini G; Donatelli G; Montesi L; Tallè M; Montironi R
    Arch Ital Urol Androl; 2016 Dec; 88(4):292-295. PubMed ID: 28073195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
    Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
    Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.
    Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C
    J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience.
    Shoji S; Hiraiwa S; Endo J; Hashida K; Tomonaga T; Nakano M; Sugiyama T; Tajiri T; Terachi T; Uchida T
    Int J Urol; 2015 Feb; 22(2):173-8. PubMed ID: 25316213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.
    Siddiqui MM; George AK; Rubin R; Rais-Bahrami S; Parnes HL; Merino MJ; Simon RM; Turkbey B; Choyke PL; Wood BJ; Pinto PA
    J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27130933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates.
    de Gorski A; Rouprêt M; Peyronnet B; Le Cossec C; Granger B; Comperat E; Cussenot O; Renard-Penna R; Mozer P
    J Urol; 2015 Sep; 194(3):669-73. PubMed ID: 25784374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approaches.
    Hong CW; Rais-Bahrami S; Walton-Diaz A; Shakir N; Su D; George AK; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
    BJU Int; 2015 May; 115(5):772-9. PubMed ID: 25045781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.
    Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R
    BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience.
    Sivaraman A; Sanchez-Salas R; Barret E; Macek P; Validire P; Galiano M; Rozet F; Cathelineau X
    World J Urol; 2015 Oct; 33(10):1475-9. PubMed ID: 25501797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.
    Verma S; Choyke PL; Eberhardt SC; Oto A; Tempany CM; Turkbey B; Rosenkrantz AB
    Radiology; 2017 Nov; 285(2):343-356. PubMed ID: 29045233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
    Junker D; Schäfer G; Heidegger I; Bektic J; Ladurner M; Jaschke W; Aigner F
    Urol Int; 2015; 94(3):313-8. PubMed ID: 25591786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.